| Year |
Citation |
Score |
| 2023 |
Cappelli L, Khan MM, Kayne A, Poiset S, Miller R, Ali A, Niazi M, Shi W, Alnahhas I. Differences in clinical outcomes based on molecular markers in glioblastoma patients treated with concurrent tumor-treating fields and chemoradiation: exploratory analysis of the SPARE trial. Chinese Clinical Oncology. 12: 23. PMID 37417289 DOI: 10.21037/cco-22-123 |
0.32 |
|
| 2022 |
Piper K, Yu S, Taghvaei M, Fernandez C, Mouchtouris N, Smit RD, Yudkoff C, Collopy S, Reyes M, Lavergne P, Karsy M, Prashant GN, Shi W, Evans J. Radiation of meningioma dural tail may not improve tumor control rates. Frontiers in Surgery. 9: 908745. PMID 35860199 DOI: 10.3389/fsurg.2022.908745 |
0.319 |
|
| 2022 |
Miller R, Song A, Ali A, Niazi M, Bar-Ad V, Martinez N, Glass J, Alnahhas I, Andrews D, Judy K, Evans J, Farrell C, Werner-Wasik M, Chervoneva I, Ly M, ... ... Shi W, et al. Scalp-Sparing Radiation With Concurrent Temozolomide and Tumor Treating Fields (SPARE) for Patients With Newly Diagnosed Glioblastoma. Frontiers in Oncology. 12: 896246. PMID 35574391 DOI: 10.3389/fonc.2022.896246 |
0.303 |
|
| 2020 |
Grosso D, Carabasi M, Filicko-O'Hara J, Wagner JL, O'Hara W, Sun M, Colombe B, Shi W, Werner-Wasik M, Rudolph S, Alpdogan O, Binder A, Kasner M, Klumpp T, Martinez-Outschoorn U, et al. Low Non-Relapse Mortality after HLA Matched Related Two-Step Hematopoietic Stem Cell Transplantation using Cyclophosphamide (CY) for Graft versus Host Disease Prophylaxis and the Potential Impact of Non-CY-Exposed T Cells on Outcomes. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 32629157 DOI: 10.1016/J.Bbmt.2020.06.021 |
0.305 |
|
| 2020 |
Shi W, Blumenthal DT, Oberheim Bush NA, Kebir S, Lukas RV, Muragaki Y, Zhu JJ, Glas M. Global post-marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high-grade glioma in clinical practice. Journal of Neuro-Oncology. PMID 32535723 DOI: 10.1007/S11060-020-03540-6 |
0.34 |
|
| 2020 |
Ali AS, Chen VE, Zurlo C, Taylor JM, Fernandez C, Shi W. Target treatment with stereotactic radiation for recurrent gliomas. Chinese Clinical Oncology. PMID 32389000 DOI: 10.21037/Cco.2020.03.05 |
0.385 |
|
| 2020 |
Fernandez C, Savard C, Farrell C, Shi W. Successful stereotactic radiotherapy of meningiomas in a patient with Cowden syndrome: a case report. Chinese Clinical Oncology. PMID 32312055 DOI: 10.21037/Cco.2020.03.04 |
0.34 |
|
| 2020 |
Song A, Bar-Ad V, Martinez N, Glass J, Andrews DW, Judy K, Evans JJ, Farrell CJ, Werner-Wasik M, Chervoneva I, Ly M, Palmer JD, Liu H, Shi W. Initial experience with scalp sparing radiation with concurrent temozolomide and tumor treatment fields (SPARE) for patients with newly diagnosed glioblastoma. Journal of Neuro-Oncology. PMID 32206976 DOI: 10.1007/S11060-020-03466-Z |
0.417 |
|
| 2020 |
Palmer JD, Bhamidipati D, Shukla G, Epperla N, Glass J, Kim L, Shi W. Outcomes after stereotactic radiosurgery for CNS lymphoma. Journal of Neuro-Oncology. PMID 32108296 DOI: 10.1007/S11060-020-03444-5 |
0.359 |
|
| 2020 |
Brown PD, Gondi V, Pugh S, Tome WA, Wefel JS, Armstrong TS, Bovi JA, Robinson C, Konski A, Khuntia D, Grosshans D, Benzinger TLS, Bruner D, Gilbert MR, Roberge D, ... ... Shi W, et al. Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1902767. PMID 32058845 DOI: 10.1200/Jco.19.02767 |
0.319 |
|
| 2020 |
Song A, Gochoco A, Zhan T, Sahu J, Alpdogan O, Porcu P, Nikbakht N, Shi W. A prospective cohort study of Condensed low dose total skin electron beam therapy for mycosis fungoides: reduction of disease burden and improvement in quality of life. Journal of the American Academy of Dermatology. PMID 32004646 DOI: 10.1016/J.Jaad.2020.01.046 |
0.301 |
|
| 2020 |
Shi W, Kleinberg L, Jeyapalan SA, Goldlust SA, Nagpal S, Reardon DA, Combs SE, Roberge D, Nishigawa R, Glas M. Phase III TRIDENT trial: Radiation and temozolomide +/- tumor treating fields in newly diagnosed glioblastoma. Journal of Clinical Oncology. 38. DOI: 10.1200/Jco.2020.38.15_Suppl.Tps2580 |
0.372 |
|
| 2020 |
Shi W, Blumenthal DT, Bush NAO, Kebir S, Lukas RV, Muragaki Y, Zhu J, Glas M. Post-marketing safety surveillance of tumor treating fields (TTFields) in patients with high-grade glioma in clinical practice. Journal of Clinical Oncology. 38: 2542-2542. DOI: 10.1200/Jco.2020.38.15_Suppl.2542 |
0.345 |
|
| 2020 |
Judy KD, Andrews DW, Harshyne L, Kenyon L, Talekar K, Atsina K, Kim L, Shi W, Werner-Wasik M, Kean R, Garcia S, Pigott K, Scott CB, Hooper DC. Abstract B71: Phase 1b/2 prospective randomized trial of four autologous cell vaccine dose cohorts for initial treatment of glioblastoma Cancer Immunology Research. 8. DOI: 10.1158/2326-6074.Tumimm18-B71 |
0.369 |
|
| 2019 |
Vergalasova I, Liu H, Alonso-Basanta M, Dong L, Li J, Nie K, Shi W, Teo BK, Yu Y, Yue NJ, Zou W, Li T. Multi-Institutional Dosimetric Evaluation of Modern Day Stereotactic Radiosurgery (SRS) Treatment Options for Multiple Brain Metastases. Frontiers in Oncology. 9: 483. PMID 31231614 DOI: 10.3389/Fonc.2019.00483 |
0.354 |
|
| 2019 |
Duffy R, Jennings T, Kartan S, Song A, Shi W, Porcu P, Alpdogan O, Sahu J. Special Considerations in the Treatment of Mycosis Fungoides. American Journal of Clinical Dermatology. PMID 30993584 DOI: 10.1007/S40257-019-00431-Z |
0.313 |
|
| 2019 |
Palmer JD, Bhamidipati D, Shukla G, Sharma D, Glass J, Kim L, Evans JJ, Judy K, Farrell C, Andrews DW, Wang ZW, Peiper SC, Werner-Wasik M, Shi W. Rapid Early Tumor Progression is Prognostic in Glioblastoma Patients. American Journal of Clinical Oncology. PMID 30973372 DOI: 10.1097/Coc.0000000000000537 |
0.41 |
|
| 2019 |
Song A, Andrews DW, Werner-Wasik M, Kim L, Glass J, Bar-Ad V, Evans JJ, Farrell CJ, Judy KD, Daskalakis C, Zhan T, Shi W. Phase I trial of alisertib with concurrent fractionated stereotactic re-irradiation for recurrent high grade gliomas. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 132: 135-141. PMID 30825962 DOI: 10.1016/J.Radonc.2018.12.019 |
0.344 |
|
| 2019 |
Martinez NL, Glass J, Shi W. Bevacizumab in recurrent glioblastoma Translational Cancer Research. 8. DOI: 10.21037/26303 |
0.351 |
|
| 2019 |
Andrews DW, Garcia S, Judy KD, Harshyne LA, Govindarajan S, Kenyon L, Talekar K, Flanders A, Atsina K, Kim L, Martinez NL, Shi W, Werner-Wasik M, Prosniak M, Curtis MT, et al. Abstract CT038: Results of a Phase Ib trial of an autologous cell vaccine for newly diagnosed glioblastoma Cancer Research. 79. DOI: 10.1158/1538-7445.Am2019-Ct038 |
0.317 |
|
| 2019 |
Song A, Ly M, Bar-Ad V, Werner-Wasik M, Glass J, Martinez N, Andrews D, Judy K, Evans J, Farrell C, Shi W. ACTR-49. INITIAL EXPERIENCE WITH SCALP PRESERVATION AND RADIATION PLUS CONCURRENT ALTERNATING ELECTRIC TUMOR-TREATING FIELDS (SPARE) FOR GLIOBLASTOMA PATIENTS Neuro-Oncology. 21: vi24-vi24. DOI: 10.1093/Neuonc/Noz175.091 |
0.423 |
|
| 2018 |
Jennings T, Duffy R, Gochoco A, Knoblauch K, Shi W, Alpdogan SO, Porcu P, Werner-Wasik M, Sahu J. Valchlor maintenance therapy for patients with mycosis fungoides who received low dose total skin electron beam treatment. Chinese Clinical Oncology. PMID 30525753 DOI: 10.21037/Cco.2018.10.01 |
0.363 |
|
| 2018 |
Chowdhary M, Song A, Zaorsky NG, Shi W. Total skin electron beam therapy in mycosis fungoides-a shift towards lower dose? Chinese Clinical Oncology. PMID 30525748 DOI: 10.21037/Cco.2018.09.02 |
0.368 |
|
| 2018 |
Blomain ES, Kim H, Garg S, Bhamidipati D, Guo J, Kalchman I, McAna J, Shi W. Stereotactic radiosurgery practice patterns for brain metastases in the United States: a national survey. Journal of Radiation Oncology. 7: 241-246. PMID 30416676 DOI: 10.1007/S13566-018-0353-8 |
0.307 |
|
| 2018 |
Li J, To D, Gunn V, Shi W, Yu Y, Liu H. Evaluation of Hybrid Arc and Volumetric-Modulated Arc Therapy Treatment Plans for Fractionated Stereotactic Intracranial Radiotherapy. Technology in Cancer Research & Treatment. 17: 1533033818802804. PMID 30343652 DOI: 10.1177/1533033818802804 |
0.383 |
|
| 2018 |
Palmer JD, Bhamidipati D, Song A, Eldredge-Hindy HB, Siglin J, Dan TD, Champ CE, Zhang I, Bar-Ad V, Kim L, Glass J, Evans JJ, Andrews DW, Werner-Wasik M, Shi W. Bevacizumab and re-irradiation for recurrent high grade gliomas: does sequence matter? Journal of Neuro-Oncology. PMID 30182159 DOI: 10.1007/S11060-018-2989-Z |
0.355 |
|
| 2018 |
Li T, Shukla G, Peng C, Lockamy V, Liu H, Shi W. Dosimetric Impact of a Tumor Treating Fields Device for Glioblastoma Patients Undergoing Simultaneous Radiation Therapy. Frontiers in Oncology. 8: 51. PMID 29594036 DOI: 10.3389/Fonc.2018.00051 |
0.398 |
|
| 2018 |
Shi W, Blomain ES, Siglin J, Palmer JD, Dan T, Wang Y, Werner-Wasik M, Glass J, Kim L, Bar Ad V, Bhamidipati D, Evans JJ, Judy K, Farrell CJ, Andrews DW. Correction to: Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment. Journal of Neuro-Oncology. PMID 29313182 DOI: 10.1007/S11060-018-2744-5 |
0.332 |
|
| 2018 |
Wefel JS, Deshmukh S, Brown PD, Grosshans DR, Sulman EP, Cerhan JH, Mehta MP, Khuntia D, Shi W, Mishra MV, Suh JH, Laack NN, Chen Y, Curtis A, Laba J, et al. Impact of apolipoprotein E (APOE) genotype on neurocognitive function (NCF) in patients with brain metastasis (BM): An analysis of NRG Oncology’s RTOG 0614. Journal of Clinical Oncology. 36: 2065-2065. DOI: 10.1200/Jco.2018.36.15_Suppl.2065 |
0.324 |
|
| 2018 |
Song A, Gowda S, Werner-Wasik M, Bar-Ad V, Kim L, Glass J, Judy K, Farrell C, Andrews D, Shi W. Rthp-10. Less Is More Or Bigger Is Better? Radiation Treatment Volume For Glioblastoma Patients Does Not Impact Survival Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy148.942 |
0.367 |
|
| 2018 |
Glas M, Kebir S, Shi W. P01.136 Safety and adverse event profile of tumor treating fields in elderly patients - a post-market surveillance analysis Neuro-Oncology. 20: iii263-iii263. DOI: 10.1093/Neuonc/Noy139.178 |
0.306 |
|
| 2018 |
Palmer J, Bhamidipati D, Shukla G, James E, Farrell C, Judy K, Kim L, Glass J, Andrews D, Werner-Wasik M, Shi W. PO-0728: Pre-Radiation Tumor Progression Improves Prognostic Stratification In Glioblastoma Patients Radiotherapy and Oncology. 127: S372. DOI: 10.1016/S0167-8140(18)31038-7 |
0.417 |
|
| 2018 |
Song A, Gowda S, Kim L, Werner-Wasik M, Andrews D, Glass J, Judy K, Farrell C, Shi W. Severe Lymphopenia after Chemoradiation Treatment is Associated with Worse Survival in Patients with Newly Diagnosed GBM International Journal of Radiation Oncology*Biology*Physics. 102: e345. DOI: 10.1016/J.Ijrobp.2018.07.1050 |
0.305 |
|
| 2017 |
Shi W, Blomain ES, Siglin J, Palmer JJ, Dan T, Wang Y, Werner-Wasik M, Glass J, Kim L, Bar Ad V, Bhamidipati D, Evans JJ, Judy K, Farrell CJ, Andrews DW. Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment. Journal of Neuro-Oncology. PMID 29235052 DOI: 10.1007/S11060-017-2709-0 |
0.392 |
|
| 2017 |
Shi W, Scannell Bryan M, Gilbert MR, Mehta MP, Blumenthal DT, Brown PD, Valeinis E, Hopkins K, Souhami L, Andrews DW, Tzuk-Shina T, Howard SP, Youssef EF, Lessard N, Dignam JJ, et al. Investigating the Effect of Reirradiation or Systemic Therapy in Patients With Glioblastoma After Tumor Progression: A Secondary Analysis of NRG Oncology/Radiation Therapy Oncology Group Trial 0525. International Journal of Radiation Oncology, Biology, Physics. PMID 29102648 DOI: 10.1016/J.Ijrobp.2017.08.038 |
0.401 |
|
| 2017 |
Williams NL, Wuthrick EJ, Kim H, Palmer JD, Garg S, Eldredge-Hindy H, Daskalakis C, Feeney KJ, Mastrangelo MJ, Kim LJ, Sato T, Kendra KL, Olencki T, Liebner DA, Farrell CJ, ... ... Shi W, et al. Phase 1 Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Patients With Brain Metastases. International Journal of Radiation Oncology, Biology, Physics. 99: 22-30. PMID 28816150 DOI: 10.1016/j.ijrobp.2017.05.028 |
0.356 |
|
| 2017 |
Li T, Shukla G, Peng C, Lockamy V, Liu H, Shi W. RTHP-04. DOSIMETRIC IMPACTS FROM A TUMOR TREATING FIELDS (TTFIELDS) DEVICE FOR GLIOBLASTOMA MULTIFORME (GBM) PATIENTS UNDERGOING SIMULTANEOUS RADIATION THERAPY Neuro-Oncology. 19: vi219-vi220. DOI: 10.1093/Neuonc/Nox168.889 |
0.399 |
|
| 2017 |
Vogelbaum M, Swanson K, Zhang P, Cahill D, Hawkins-Daarud A, Gilbert MR, De Leon G, Rickertsen C, Kunkel L, Shi W, Penas-Prado M, Youssef E, Shu H, Wendland M, Suh J, et al. NIMG-77. IMPACT OF POST-SURGICAL ENHANCING TUMOR VOLUME AND T2/FLAIR VOLUME ON THE SURVIVAL IMPACT OF BEVACIZUMAB IN NRG ONCOLOGY/RTOG 0825 Neuro-Oncology. 19: vi159-vi160. DOI: 10.1093/Neuonc/Nox168.649 |
0.332 |
|
| 2017 |
Manukian G, Garg S, Mark J, Werner-wasik M, Andrews D, Evans J, Judy K, Farrell C, Shi W. Cmet-34. Comparing Stereotactic Radiosurgery With Whole Brain Radiation Therapy In The Treatment Of Renal Cell Carcinoma Brain Metastases Neuro-Oncology. 19. DOI: 10.1093/Neuonc/Nox168.181 |
0.329 |
|
| 2017 |
Gochoco A, Kornreich D, Kasner M, Alpdogan O, Shi W, Sahu J. 147 Primary aleukemic myeloid leukemia cutis remission following radiotherapy Journal of Investigative Dermatology. 137: S25. DOI: 10.1016/J.Jid.2017.02.161 |
0.305 |
|
| 2017 |
Song A, Andrews D, Ad VB, Judy K, Glass J, Kim L, Lombardo J, Evans J, Farrell C, Shi W. Phase 1 Study of Alisertib With Concurrent Fractionated Stereotactic Radiation Treatment for Recurrent High Grade Gliomas International Journal of Radiation Oncology*Biology*Physics. 99: E110. DOI: 10.1016/J.Ijrobp.2017.06.857 |
0.362 |
|
| 2017 |
Ali A, Garg S, Kim L, Glass J, Leiby B, Dabbish N, Werner-Wasik M, Shi W. Comparing Outcomes of Patients Treated With Radiation Therapy With or Without Concurrent and Adjuvant Temozolomide After Surgical Resection for Newly Diagnosed WHO Grade 3 Anaplastic Astrocytoma International Journal of Radiation Oncology*Biology*Physics. 99: E62. DOI: 10.1016/J.Ijrobp.2017.06.738 |
0.366 |
|
| 2016 |
Gilani MA, Williams NL, Giordano C, Rosenblum N, Shi W, Anne P, Schilder RJ. Brain Metastases in Patients with Gynecologic Cancers: A Single Institution Experience and Review of the Literature. Open Journal of Obstetrics and Gynecology. 6: 544-552. PMID 31552146 DOI: 10.4236/Ojog.2016.69070 |
0.304 |
|
| 2016 |
Garg S, Palmer JD, Kim H, Williams NL, Bhamidipati D, Skowronski J, Glass J, Werner-Wasik M, Kim L, Shi W. Hypofractionated Radiation Therapy With Concurrent Temozolamide for Recurrent High-Grade Glioma. International Journal of Radiation Oncology, Biology, Physics. 96: E95. PMID 27675511 DOI: 10.1016/J.Ijrobp.2016.06.831 |
0.37 |
|
| 2016 |
Palmer JD, Shukla G, Bhamidipati D, Skowronski J, Kim H, Judy KD, Evans JJ, Farrell CJ, Andrews DW, Kim L, Glass J, Werner-Wasik M, Shi W. Early Tumor Progression Prior to Adjuvant Therapy May Predict Survival in Newly Diagnosed Glioblastoma. International Journal of Radiation Oncology, Biology, Physics. 96: E117-E118. PMID 27673820 DOI: 10.1016/J.Ijrobp.2016.06.886 |
0.364 |
|
| 2016 |
Williams NL, Keller J, Kremmel E, Lockamy VL, Harrison AS, Shi W. Scalp-sparing total skin electron therapy in mycosis fungoides: Case report highlighting technique and outcome. Practical Radiation Oncology. PMID 27156426 DOI: 10.1016/J.Prro.2016.02.007 |
0.358 |
|
| 2016 |
Kim H, Leiby BE, Shi W. Too Little, Too Soon: Short-Course Radiotherapy in Elderly Patients With Glioblastoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 27069070 DOI: 10.1200/Jco.2015.66.3195 |
0.31 |
|
| 2016 |
Shi W, Jain V, Kim H, Champ C, Jain G, Farrell C, Andrews DW, Judy K, Liu H, Artz G, Werner-Wasik M, Evans JJ. Fractionated Stereotactic Radiotherapy for Facial Nerve Schwannomas. Journal of Neurological Surgery. Part B, Skull Base. 77: 75-80. PMID 26949592 DOI: 10.1055/S-0035-1564056 |
0.37 |
|
| 2016 |
Liu H, Andrews DW, Evans JJ, Werner-Wasik M, Yu Y, Dicker AP, Shi W. Plan Quality and Treatment Efficiency for Radiosurgery to Multiple Brain Metastases: Non-Coplanar RapidArc vs. Gamma Knife. Frontiers in Oncology. 6: 26. PMID 26904504 DOI: 10.3389/Fonc.2016.00026 |
0.348 |
|
| 2016 |
Shi W, Palmer JD, Werner-Wasik M, Andrews DW, Evans JJ, Glass J, Kim L, Bar-Ad V, Judy K, Farrell C, Simone N, Liu H, Dicker AP, Lawrence YR. Phase I trial of panobinostat and fractionated stereotactic re-irradiation therapy for recurrent high grade gliomas. Journal of Neuro-Oncology. PMID 26821711 DOI: 10.1007/S11060-016-2059-3 |
0.358 |
|
| 2016 |
Shukla G, Palmer J, Li T, Lockamy V, Peng C, Shi W. RTHP-34. PLACEMENT OF SCALP ELECTRODES (NOVO TTF) DOES NOT SIGNIFICANTLY CHANGE RADIATION DOSIMETRY WHEN DELIVERING CRANIAL INTENSITY MODULATED RADIATION THERAPY (IMRT) Neuro-Oncology. 18: vi181-vi181. DOI: 10.1093/Neuonc/Now212.759 |
0.327 |
|
| 2016 |
Shukla G, Palmer J, Glass J, Kim L, Shi W. RTHP-33. OUTCOMES AFTER STEREOTACTIC RADIATION THERAPY FOR PRIMARY CNS LYMPHOMA Neuro-Oncology. 18: vi181-vi181. DOI: 10.1093/Neuonc/Now212.758 |
0.339 |
|
| 2016 |
Palmer J, Shukla G, Mollaee M, Sharma D, Skowronski J, Bhamidipati D, Champ C, Glass J, Kim L, Judy K, Evans J, Farrell C, Andrews D, Peiper S, Shi W, et al. NIMG-67. PRE-RADIATION TUMOR PROGRESSION IMPROVES PROGNOSTIC STRATIFICATION IN GLIOBLASTOMA PATIENTS Neuro-Oncology. 18: vi139-vi139. DOI: 10.1093/Neuonc/Now212.578 |
0.417 |
|
| 2015 |
Shi W, Dicker AP. CNS Metastases in Patients With Non-Small-Cell Lung Cancer and ALK Gene Rearrangement. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26628475 DOI: 10.1200/Jco.2015.63.9682 |
0.376 |
|
| 2015 |
Palmer JD, Siglin J, Yamoah K, Dan T, Champ CE, Bar-Ad V, Werner-Wasik M, Evans JJ, Kim L, Glass J, Farrell C, Andrews DW, Shi W. Re-resection for recurrent high-grade glioma in the setting of re-irradiation: more is not always better. Journal of Neuro-Oncology. PMID 26024653 DOI: 10.1007/S11060-015-1825-Y |
0.36 |
|
| 2015 |
Kim H, Potrebko P, Rivera A, Liu H, Eldredge-Hindy HB, Gunn V, Werner-Wasik M, Andrews DW, Evans JJ, Farrell CJ, Judy K, Shi W. Tumor volume threshold for achieving improved conformity in VMAT and Gamma Knife stereotactic radiosurgery for vestibular schwannoma. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 115: 229-34. PMID 25998805 DOI: 10.1016/J.Radonc.2015.03.031 |
0.342 |
|
| 2015 |
Shi W. Role for radiation therapy in melanoma. Surgical Oncology Clinics of North America. 24: 323-35. PMID 25769715 DOI: 10.1016/J.Soc.2014.12.009 |
0.413 |
|
| 2015 |
Shukla G, Lockamy V, Keller J, Sahu J, Pro B, Alpdogan O, Shi W. High Dose Rate (HDR) Brachytherapy for Mycosis Fungoides of the Wrist International Journal of Clinical Medicine. 6: 154-157. DOI: 10.4236/Ijcm.2015.63020 |
0.379 |
|
| 2015 |
Shi W, Siglin J, Palmer j, Dan T, Werner-wasik M, Glass J, Kim L, Ad VB, Evans J, Judy K, Farrell C, Andrews D. Rtrb-18Salvage Fractionated Stereotactic Re-Irradiation (Fsrt) For Patients With Recurrent High Grade Gliomas Progressed After Bevacizumab Treatment Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov231.18 |
0.369 |
|
| 2015 |
Palmer J, Bhamidipati D, Barsoom R, Skowronski J, Evans J, Judy K, Farrell C, Andrews D, Glass J, Werner-Wasik M, Shi W, Kim L. RTRB-15CONCURRENT TEMOZOLOMIDE AND HYPOFRACTIONATED RADIOTHERAPY FOR RECURRENT HIGH GRADE GLIOMA Neuro-Oncology. 17: v198.3-v198. DOI: 10.1093/Neuonc/Nov231.15 |
0.334 |
|
| 2015 |
Palmer J, Mehta M, Williams N, Dicker A, Werner-Wasik M, Shi W. Rtrb-14Treatment Recommendations For Elderly Patients With Newly Diagnosed Glioblastoma Lack Worldwide Consensus Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov231.14 |
0.327 |
|
| 2015 |
Luo D, Sarkisian M, McIntyre J, Shi W, Kenyon L, Harrison J. IMPS-12CCR2 DEFICIENCY REDUCES THE INFLUX OF CD11b+ MACROPHAGES IN MURINE GLIOMAS Neuro-Oncology. 17: v115.3-v115. DOI: 10.1093/Neuonc/Nov217.12 |
0.347 |
|
| 2015 |
Shi W, Bryan M, Gilbert M, Mehta M, Blumenthal D, Brown P, Valeinis E, Hopkins K, Souhami L, Andrews D, Tzahala T, Howard S, Youssef E, Lessard N, Dignam J, et al. ATCT-29INVESTIGATING THE EFFECT OF REIRRADIATION OR SYSTEMIC THERAPY IN PATIENTS WITH GBM AFTER TUMOR PROGRESSION: A SECONDARY ANALYSIS OF THE NRG ONCOLOGY/RTOG 0525 Neuro-Oncology. 17: v8.1-v8. DOI: 10.1093/Neuonc/Nov206.29 |
0.398 |
|
| 2015 |
Kim H, Potrebko P, Rivera A, Liu H, Eldredge-Hindy H, Gunn V, Werner-Wasik M, Andrews D, Evans J, Farrell C, Judy K, Shi W. Tumor Volume Threshold for Achieving Improved Conformity Index in VMAT and Gamma Knife Stereotactic Radiosurgery for Vestibular Schwannoma Journal of Neurological Surgery Part B: Skull Base. 76. DOI: 10.1055/S-0035-1546581 |
0.351 |
|
| 2015 |
Shi W, Siglin J, Palmer J, Champ C, Dan T, Werner-Wasik M, Glass J, Kim L, Ad VB, Evans J, Judy K, Farrell C, Andrews D. Fractionated Stereotactic Reirradiation (FSRT) for Patients With Recurrent High Grade Gliomas Who Progressed After Bevacizumab Treatment International Journal of Radiation Oncology*Biology*Physics. 93: E74. DOI: 10.1016/J.Ijrobp.2015.07.732 |
0.362 |
|
| 2015 |
Palmer J, Werner-Wasik M, Andrews D, Evans J, Glass J, Kim L, Judy K, Farrell C, Ad VB, Simone N, Dicker A, Shi W. Phase 2, Open-Label, Trial Evaluating Safety, Tolerability, and Preliminary Antitumor Activity of Panobinostat and Fractionated Stereotactic Reirradiation Therapy for Recurrent High-Grade Gliomas International Journal of Radiation Oncology*Biology*Physics. 93: S109-S110. DOI: 10.1016/J.Ijrobp.2015.07.262 |
0.323 |
|
| 2014 |
Witek M, Vahknenko Y, Siglin J, Harrison A, Xiao Y, Lui H, Andrews D, Shi W. Dose Reduction to the Scalp with Hippocampal Sparing Is Achievable with Intensity Modulated Radiotherapy. International Journal of Medical Physics, Clinical Engineering and Radiation Oncology. 3: 176-182. PMID 29963335 DOI: 10.4236/Ijmpcero.2014.33023 |
0.357 |
|
| 2014 |
Siglin J, Champ CE, Vakhnenko Y, Witek ME, Peng C, Zaorsky NG, Harrison AS, Shi W. Optimizing patient positioning for intensity modulated radiation therapy in hippocampal-sparing whole brain radiation therapy. Practical Radiation Oncology. 4: 378-83. PMID 25407858 DOI: 10.1016/J.Ijrobp.2011.06.1378 |
0.369 |
|
| 2014 |
Wuthrick EJ, Curran WJ, Camphausen K, Lin A, Glass J, Evans J, Andrews DW, Axelrod R, Shi W, Werner-Wasik M, Haacke EM, Hillman GG, Dicker AP. A pilot study of hypofractionated stereotactic radiation therapy and sunitinib in previously irradiated patients with recurrent high-grade glioma. International Journal of Radiation Oncology, Biology, Physics. 90: 369-75. PMID 25104067 DOI: 10.1016/J.Ijrobp.2014.05.034 |
0.414 |
|
| 2014 |
Shi W, Lawrence YR, Choy H, Werner-Wasik M, Andrews DW, Evans JJ, Judy KD, Farrell CJ, Moshel Y, Berger AC, Bar-Ad V, Dicker AP. Vorinostat as a radiosensitizer for brain metastasis: a phase I clinical trial. Journal of Neuro-Oncology. 118: 313-9. PMID 24728831 DOI: 10.1007/S11060-014-1433-2 |
0.362 |
|
| 2014 |
Champ CE, Palmer JD, Volek JS, Werner-Wasik M, Andrews DW, Evans JJ, Glass J, Kim L, Shi W. Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme. Journal of Neuro-Oncology. 117: 125-31. PMID 24442482 DOI: 10.1007/S11060-014-1362-0 |
0.324 |
|
| 2014 |
Dai Y, Siemann D, Shi W. Abstract 5507: Activation of a subset of growth factor-associated genes in cetuximab-sensitive colorectal cancer GEO cells with KRAS mutation Cancer Research. 74: 5507-5507. DOI: 10.1158/1538-7445.Am2014-5507 |
0.523 |
|
| 2014 |
Siglin J, Palmer J, Champ C, Eldredge-Hindy H, Glass J, Kim L, Evans J, Andrews D, Werner-Wasik M, Shi W. Rt-31Survival Outcomes In Patients Receiving Both Fractionated Stereotactic Radiotherapy And Bevacizumab For Recurrent High Grade Glioma. Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou270.27 |
0.354 |
|
| 2014 |
Palmer J, Siglin J, Yamoah K, Dan T, Champ C, Kim L, Glass J, Werner-Wasik M, Farrell C, Evans J, Andrews D, Shi W. RT-26 * RE-RESECTION FOR RECURRENT HIGH GRADE GLIOMA IN THE SETTING OF RE-IRRADIATION: SURVIVAL OUTCOMES UPDATE Neuro-Oncology. 16: v193-v193. DOI: 10.1093/Neuonc/Nou270.23 |
0.324 |
|
| 2014 |
Shi W, Lawrence YR, Werner-wasik M, Evans J, Andrews D, Glass J, Kim L, Ad VB, Moshel Y, Judy K, Farrell C, Simon N, Dicker A. AT-51 * PHASE I STUDY OF PANOBINOSTAT AND FRACTIONATED STEREOTACTIC RE-IRRADIATION THERAPY (FSRT) FOR RECURRENT HIGH GRADE GLIOMAS Neuro-Oncology. 16: v19-v20. DOI: 10.1093/Neuonc/Nou237.50 |
0.32 |
|
| 2014 |
Shi W, Lawrence Y, Werner-Wasik M, Andrews D, Evans J, Glass J, Kim L, Ad VB, Moshel Y, Judy K, Farrell C, Simon N, Dicker A. 216 Phase I study of panobinostat and fractionated stereotactic re-irradiation therapy (FSRT) for recurrent high grade gliomas European Journal of Cancer. 50: 73. DOI: 10.1016/S0959-8049(14)70342-9 |
0.348 |
|
| 2013 |
Shi W, Nichols RC, Flampouri S, Li Z, Hsi W, Huh S, Ho MW, Henderson RH, Mendenhall NP, Hoppe BS. Proton-based chemoradiation for synchronous bilateral non-small-cell lung cancers: A case report. Thoracic Cancer. 4: 198-202. PMID 28920189 DOI: 10.1111/J.1759-7714.2012.00141.X |
0.366 |
|
| 2013 |
Champ CE, Shen X, Shi W, Mayekar SU, Chapman K, Werner-Wasik M, Farrell CJ, Gunn V, Downes MB, Liu H, Evans JJ, Andrews DW. Reduced-dose fractionated stereotactic radiotherapy for acoustic neuromas: maintenance of tumor control with improved hearing preservation. Neurosurgery. 73: 489-96. PMID 23756743 DOI: 10.1227/Neu.0000000000000019 |
0.368 |
|
| 2013 |
Studenski MT, Shen X, Yu Y, Xiao Y, Shi W, Biswas T, Werner-Wasik M, Harrison AS. Intensity-modulated radiation therapy and volumetric-modulated arc therapy for adult craniospinal irradiation--a comparison with traditional techniques. Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists. 38: 48-54. PMID 22878118 DOI: 10.1016/J.Meddos.2012.05.006 |
0.33 |
|
| 2013 |
Shi W, Indelicato DJ, Reith J, Smith KB, Morris CG, Scarborough MT, Gibbs CP, Mendenhall WM, Zlotecki RA. Radiotherapy in the management of giant cell tumor of bone. American Journal of Clinical Oncology. 36: 505-8. PMID 22781387 DOI: 10.1016/J.Ijrobp.2010.07.1434 |
0.358 |
|
| 2013 |
Shi W, Lawrence YR, Choy H, Wachsberger PR, Andrews DW, Werner-Wasik M, Dicker A. Vorinostat as a radiosensitizer for CNS malignancies: Preclinical results and phase I trial in brain metastasis. Journal of Clinical Oncology. 31: 2100-2100. DOI: 10.1200/Jco.2013.31.15_Suppl.2100 |
0.379 |
|
| 2013 |
Shi W, Lawrence YR, Werner-Wasik M, Andrews D, Ad VB, Evans J, Moshel Y, Farrell C, Judy K, Glass J, Kim L, Dicker AP. Abstract B83: Phase I trial of panobinostat and fractionated stereotactic radiation therapy for recurrent glioma. Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Targ-13-B83 |
0.409 |
|
| 2013 |
Palmer J, Siglin J, Champ C, Dan T, Werner-Wasik M, Andrews D, Evans J, Shi W. Re-resection for Recurrent High-Grade Glioma in the Setting of Re-irradiation International Journal of Radiation Oncology*Biology*Physics. 87: S160. DOI: 10.1016/J.Ijrobp.2013.06.413 |
0.306 |
|
| 2013 |
Siglin J, Champ C, Zhang I, Dan T, Glass J, Evans J, Andrews D, Werner-Wasik M, Shi W. Combining Fractionated Stereotactic Radiation Therapy and Bevacizumab for Recurrent High-Grade Glioma: Outcomes Analysis International Journal of Radiation Oncology*Biology*Physics. 87: S159. DOI: 10.1016/J.Ijrobp.2013.06.411 |
0.369 |
|
| 2013 |
Werner-Wasik M, Pequignot E, Campling B, Shi W, Bhatia A, Wang Z, Shipman K, Dougherty E, Myers C, Axelrod R. A Phase 2 Study of Erlotinib (ERL) and Hypofractionated Thoracic Radiation Therapy (HRT) in Patients (Pts) With Non-Small Cell Lung Cancer (NSCLC) and Comorbidities International Journal of Radiation Oncology Biology Physics. 87. DOI: 10.1016/J.Ijrobp.2013.06.1342 |
0.319 |
|
| 2012 |
Champ CE, Siglin J, Mishra MV, Shen X, Werner-Wasik M, Andrews DW, Mayekar SU, Liu H, Shi W. Evaluating changes in radiation treatment volumes from post-operative to same-day planning MRI in High-grade gliomas. Radiation Oncology (London, England). 7: 220. PMID 23259933 DOI: 10.1186/1748-717X-7-220 |
0.404 |
|
| 2012 |
Siemann DW, Dong M, Pampo C, Shi W. Src-signaling interference impairs the dissemination of blood-borne tumor cells. Cell and Tissue Research. 349: 541-50. PMID 22526632 DOI: 10.1007/S00441-012-1415-7 |
0.689 |
|
| 2012 |
Champ CE, Mishra MV, Shi W, Siglin J, Werner-Wasik M, Andrews DW, Evans JJ. Stereotactic radiotherapy for trigeminal schwannomas. Neurosurgery. 71: 270-7; discussion 27. PMID 22472550 DOI: 10.1227/Neu.0B013E318256Bbc5 |
0.372 |
|
| 2012 |
Yoon W, Kim J, Han Y, Chung D, Park Y, Lizarraga KJ, Allen-Auerbach M, De Salles AA, Yong WH, Chen W, Ruge MI, Kickingereder P, Simon T, Treuer H, Sturm V, ... ... Shi W, et al. CLIN-RADIATION THERAPY Neuro-Oncology. 14: vi133-vi141. DOI: 10.1093/Neuonc/Nos238 |
0.331 |
|
| 2012 |
Zaorsky N, Shi W, Gunn V, Werner-Wasik M, Farrell C, Andrews DW. Fractionated Stereotactic Radiation Therapy and Stereotactic Radiosurgery for the Treatment of Olfactory Groove Meningiomas: Observations of 13 Patients With or Without Prior Surgery International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.722 |
0.353 |
|
| 2012 |
Mayekar S, Champ C, Mishra M, Siglin J, Werner-Wasik M, Dicker A, Andrews D, Liu H, Shi W. Evaluating Changes in Radiation Treatment Volumes and Outcomes From Postoperative to Same-day Planning MRI in High Grade Gliomas: A Prospective Study International Journal of Radiation Oncology*Biology*Physics. 84: S266. DOI: 10.1016/J.Ijrobp.2012.07.692 |
0.336 |
|
| 2012 |
Champ CE, Mayekar S, Mishra MV, Andrews DW, Werner-Wasik M, Chapman K, Gunn V, Liu H, Evans JJ, Shi W. Long-term Outcomes of Low-dose Fractionated Stereotactic Radiation Therapy of 46.8 Gy for Acoustic Schwannomas International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.105 |
0.336 |
|
| 2011 |
Ohri N, Shi W, Dicker A, Showalter TN. Late toxicity rates following definitive radiotherapy for prostate cancer: A meta-analysis revealing interactions between dose and technique. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 4608. PMID 28024018 DOI: 10.1200/Jco.2011.29.15_Suppl.4608 |
0.318 |
|
| 2011 |
Lu B, Li J, Kahler D, Yan G, Mittauer K, Shi W, Okunieff P, Liu C. An approach for online evaluations of dose consequences caused by small rotational setup errors in intracranial stereotactic radiation therapy. Medical Physics. 38: 6203-15. PMID 22047385 DOI: 10.1118/1.3656954 |
0.331 |
|
| 2011 |
Champ CE, Siglin J, Shen X, Werner-Wasik M, Dicker A, Andrews D, Liu H, Ahn P, Shi W. Can the Volume of Irradiated Normal Tissue Be Decreased in Patients with High Grade Gliomas? A Prospective Study Evaluating Changes in Radiation Treatment Volumes from Post-Operative to Same-Day Planning MRI International Journal of Radiation Oncology Biology Physics. 81. DOI: 10.1016/J.Ijrobp.2011.06.468 |
0.337 |
|
| 2010 |
Shi W, Liu C, Lu B, Yeung A, Newlin HE, Amdur RJ, Olivier KR. The effect of intravenous contrast on photon radiation therapy dose calculations for lung cancer. American Journal of Clinical Oncology. 33: 153-6. PMID 19806038 DOI: 10.1097/Coc.0B013E3181A44637 |
0.361 |
|
| 2009 |
Siemann DW, Norris CM, Ryan A, Shi W. Impact of tumor cell VEGF expression on the in vivo efficacy of vandetanib (ZACTIMA; ZD6474). Anticancer Research. 29: 1987-92. PMID 19528456 |
0.512 |
|
| 2009 |
Yeung AR, Li JG, Shi W, Newlin HE, Chvetsov A, Liu C, Palta JR, Olivier K. Tumor localization using cone-beam CT reduces setup margins in conventionally fractionated radiotherapy for lung tumors. International Journal of Radiation Oncology, Biology, Physics. 74: 1100-7. PMID 19395197 DOI: 10.1016/J.Ijrobp.2008.09.048 |
0.336 |
|
| 2008 |
Siemann DW, Shi W. Dual targeting of tumor vasculature: combining Avastin and vascular disrupting agents (CA4P or OXi4503). Anticancer Research. 28: 2027-31. PMID 18751370 |
0.475 |
|
| 2008 |
Shi W, Indelicato DJ, Keole SR, Morris CG, Scarborough MT, Gibbs PC, Zlotecki RA. Radiation treatment for Ewing family of tumors in adults: the University of Florida experience. International Journal of Radiation Oncology, Biology, Physics. 72: 1140-5. PMID 18513886 DOI: 10.1016/J.Ijrobp.2008.02.071 |
0.369 |
|
| 2008 |
Indelicato DJ, Keole SR, Shahlaee AH, Shi W, Morris CG, Marcus RB. Definitive radiotherapy for ewing tumors of extremities and pelvis: long-term disease control, limb function, and treatment toxicity. International Journal of Radiation Oncology, Biology, Physics. 72: 871-7. PMID 18455323 DOI: 10.1016/J.Ijrobp.2008.02.023 |
0.364 |
|
| 2008 |
Indelicato DJ, Keole SR, Shahlaee AH, Shi W, Morris CG, Gibbs CP, Scarborough MT, Marcus RB. Long-term clinical and functional outcomes after treatment for localized Ewing's tumor of the lower extremity. International Journal of Radiation Oncology, Biology, Physics. 70: 501-9. PMID 17855013 DOI: 10.1016/J.Ijrobp.2007.06.032 |
0.345 |
|
| 2008 |
Yeung A, Li J, Shi W, Newlin H, Chvetsov A, Liu C, Palta J, Olivier K. Tumor Localization using Cone-beam Computed Tomography Reduces Setup Margin in Conventionally Fractionated Radiotherapy for Lung Tumors International Journal of Radiation Oncology*Biology*Physics. 72: S446. DOI: 10.1016/J.Ijrobp.2008.06.1825 |
0.338 |
|
| 2008 |
Indelicato DJ, Keole SR, Shahlaee AH, Shi W, Morris CG, Marcus RB. Poster Viewing PresentationDefinitive Radiotherapy for Ewing Tumors of the Extremities and Pelvis: Long-term Disease Control, Limb Function and Treatment Toxicity International Journal of Radiation Oncology Biology Physics. 72. DOI: 10.1016/J.Ijrobp.2008.06.1450 |
0.343 |
|
| 2006 |
Norris CM, Shi W, Siemann DW. Impact of VEGF expression on the physiological characteristics of clonal cell lines. In Vivo (Athens, Greece). 20: 815-21. PMID 17203773 |
0.459 |
|
| 2006 |
Shi W, Siemann DW. Augmented antitumor effects of radiation therapy by 4-1BB antibody (BMS-469492) treatment. Anticancer Research. 26: 3445-53. PMID 17094465 |
0.499 |
|
| 2006 |
Brazelle WD, Shi W, Siemann DW. VEGF-associated tyrosine kinase inhibition increases the tumor response to single and fractionated dose radiotherapy. International Journal of Radiation Oncology, Biology, Physics. 65: 836-41. PMID 16751064 DOI: 10.1016/J.Ijrobp.2006.02.023 |
0.557 |
|
| 2006 |
Teschendorf C, Warrington KH, Shi W, Siemann DW, Muzyczka N. Recombinant adeno-associated and adenoviral vectors for the transduction of pancreatic and colon carcinoma. Anticancer Research. 26: 311-7. PMID 16475712 |
0.712 |
|
| 2006 |
Otero J, Russell KJ, Fu D, Shi W, Jorgensen ML, Guthrie SM, Siemann D, Scott EW, Cogle CR. Tumor Vasculogenesis Can Be Derived from the Hematopoietic Stem Cell. Blood. 108: 1806-1806. DOI: 10.1182/Blood.V108.11.1806.1806 |
0.562 |
|
| 2005 |
Shi W, Siemann DW. Preclinical studies of the novel vascular disrupting agent MN-029. Anticancer Research. 25: 3899-904. PMID 16309177 |
0.494 |
|
| 2005 |
Shi W, Siemann DW. Targeting the tumor vasculature: enhancing antitumor efficacy through combination treatment with ZD6126 and ZD6474. In Vivo (Athens, Greece). 19: 1045-50. PMID 16277020 |
0.502 |
|
| 2004 |
Siemann DW, Shi W. Efficacy of combined antiangiogenic and vascular disrupting agents in treatment of solid tumors. International Journal of Radiation Oncology, Biology, Physics. 60: 1233-40. PMID 15519796 DOI: 10.1016/J.Ijrobp.2004.08.002 |
0.56 |
|
| 2004 |
Shi W, Siemann DW. Simultaneous targeting of VEGF message and VEGF receptor signaling as a therapeutic anticancer approach. Anticancer Research. 24: 213-8. PMID 15015599 |
0.457 |
|
| 2004 |
Siemann D, Shi W. Monoclonal Antibodies Against 4-1BB Enhance the Antitumor Effects of Radiation Journal of Immunotherapy. 27: S11. DOI: 10.1097/00002371-200411000-00044 |
0.505 |
|
| 2003 |
Shi W, Teschendorf C, Muzyczka N, Siemann DW. Gene therapy delivery of endostatin enhances the treatment efficacy of radiation. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 66: 1-9. PMID 12559515 DOI: 10.1016/S0167-8140(02)00280-3 |
0.595 |
|
| 2003 |
Siemann DW, Shi W. Targeting the tumor blood vessel network to enhance the efficacy of radiation therapy Seminars in Radiation Oncology. 13: 53-61. PMID 12520464 DOI: 10.1053/Srao.2003.50005 |
0.597 |
|
| 2002 |
Shi W, Siemann DW. Inhibition of renal cell carcinoma angiogenesis and growth by antisense oligonucleotides targeting vascular endothelial growth factor British Journal of Cancer. 87: 119-126. PMID 12085267 DOI: 10.1038/sj.bjc.6600416 |
0.455 |
|
| 2002 |
Shi W, Teschendorf C, Muzyczka N, Siemann DW. Adeno-associated virus-mediated gene transfer of endostatin inhibits angiogenesis and tumor growth in vivo. Cancer Gene Therapy. 9: 513-21. PMID 12032662 DOI: 10.1038/Sj.Cgt.7700463 |
0.555 |
|
| Show low-probability matches. |